Press Releases

Date

Title

View

19 Dec 19

Expedeon AG: Expedeon shareholders approve sale of proteomics & immunotherapy business and name change to 4basebio AG (news with additional features)

View View

21 Nov 19

Expedeon AG: Expedeon to Present at the Deutsches Eigenkapitalforum in Frankfurt / Main (news with additional features)

View View

20 Nov 19

Expedeon AG: Expedeon AG information on EUR 120 million deal with Abcam on dedicated transaction website (news with additional features)

View View

11 Nov 19

Expedeon AG: Expedeon AG signs EUR 120 million deal with Abcam for the sale of its immunology and proteomics business

View View

07 Nov 19

Expedeon AG: Expedeon AG reports third quarter 2019 financial results with strongest ever revenues and EBITDA (news with additional features)

View View

29 Oct 19

Expedeon AG: Expedeon AG raises adjusted EBITDA guidance for 2019 (news with additional features)

View View

04 Oct 19

Expedeon AG: Expedeon AG announces conversion to registered shares (news with additional features)

View View

14 Aug 19

Expedeon AG: Expedeon AG reports strong financial results for the first six months of 2019, reaffirming positive trend (news with additional features)

View View

06 Aug 19

Expedeon AG: Expedeon AG signs commercial agreement with Sona Nanotech (news with additional features)

View View

10 Jul 19

Expedeon AG: Expedeon AG announces outcome of Annual General Meeting 2019 (news with additional features)

View View

24 Jun 19

Expedeon AG: Expedeon AG introduces Lightning-Link(R) Metal Labelling Kits to support single cell analysis (news with additional features)

View View

12 Jun 19

Expedeon AG: Expedeon AG mandates ODDO SEYDLER BANK AG as Designated Sponsor (news with additional features)

View View